• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非慢性感染的囊性纤维化患者的微生物学:关于两种不同上呼吸道采样方法的准实验研究

Microbiology of cystic fibrosis persons not chronically infected with : A quasi-experimental study on two different upper airways' sampling methods.

作者信息

Dolce Daniela, Ravenni Novella, Fevola Cristina, Francalanci Michela, Bonomi Paolo, Cavicchi Maria Chiara, Galici Valeria, Neri Anna Silvia, Taccetti Giovanni, Terlizzi Vito, Innocenti Diletta, Ferrari Beatrice, Bianchimani Chiara, Camera Erica, Orioli Tommaso, Campana Silvia

机构信息

Meyer Children's Hospital IRCCS, Cystic Fibrosis Regional Reference Centre, Department of Paediatric Medicine, Florence, 50139, Italy.

Freelance Statistician, Milan, 20146, Italy.

出版信息

Heliyon. 2024 Feb 29;10(5):e26978. doi: 10.1016/j.heliyon.2024.e26978. eCollection 2024 Mar 15.

DOI:10.1016/j.heliyon.2024.e26978
PMID:38449646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10915376/
Abstract

BACKGROUND

The upper airways of cystic fibrosis (CF) persons are an evolutionary niche where genetically adapted bacterial strains are selected for lung infection. The microbiological studies conducted up to now on the upper airways are not easily comparable.

METHODS

Using classical culture methods, we simultaneously studied the microbiological status of upper and lower airways in persons not chronically infected with . Each person had a single upper airways sampling and a concomitant lower airways sampling. Lower airways sampling was performed by oropharyngeal swab or sputum collection. Using a quasi-experimental design of study, we evaluated the performance of 2 different upper airways' sampling methods, nasal lavage according to method described by Mainz or nasal lavage with a rhino-set. Pain was measured with appropriate scales.

RESULTS

A total of 194 persons were enrolled in this study. Pathogenic flora was found in 128 (6.6%) of 194 upper airways samples and in 164 (84.6%) lower airways samples. A statistically significant difference between the upper airways and the lower airways was found in the isolation of and non-fermenter gram negatives. Nasal lavage according to Mainz resulted in the isolation of more non-fermenter gramnegatives than the rhino-set (p < 0.05). No differences were found in the pain caused bythe two methods.

CONCLUSIONS

In our study population, cultures of the upper airway and lower airway differ in CF persons. In people sampled with nasal lavage according to Mainz more non-fermenter gram negatives were detected than with rhino-set. The two sampling methods were comparable with regard to the caused pain, nasal lavage according to Mainz method being quicker to perform.

摘要

背景

囊性纤维化(CF)患者的上呼吸道是一个进化生态位,在此会选择基因适应的细菌菌株用于肺部感染。目前对上呼吸道进行的微生物学研究不易进行比较。

方法

我们使用经典培养方法,同时研究了未慢性感染的患者上呼吸道和下呼吸道的微生物学状况。每位患者进行一次上呼吸道采样和一次同步的下呼吸道采样。下呼吸道采样通过口咽拭子或痰液采集进行。采用准实验研究设计,我们评估了两种不同的上呼吸道采样方法的性能,即根据美因茨描述的方法进行鼻腔灌洗或使用鼻用套件进行鼻腔灌洗。使用适当的量表测量疼痛程度。

结果

本研究共纳入194名患者。在194份上呼吸道样本中的128份(6.6%)和164份下呼吸道样本中的164份(84.6%)中发现了致病菌群。在上呼吸道和下呼吸道分离出的[具体细菌名称未给出]和非发酵革兰氏阴性菌方面存在统计学显著差异。根据美因茨方法进行的鼻腔灌洗分离出的非发酵革兰氏阴性菌比鼻用套件更多(p < 0.05)。两种方法引起的疼痛没有差异。

结论

在我们的研究人群中,CF患者的上呼吸道和下呼吸道培养结果不同。根据美因茨方法进行鼻腔灌洗采样的患者中检测到的非发酵革兰氏阴性菌比使用鼻用套件的患者更多。两种采样方法在引起的疼痛方面具有可比性,根据美因茨方法进行鼻腔灌洗操作更快。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/ec94faaadd50/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/533b521eecae/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/8f49d9070d25/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/1316e84415e2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/ec94faaadd50/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/533b521eecae/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/8f49d9070d25/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/1316e84415e2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e6e/10915376/ec94faaadd50/gr4.jpg

相似文献

1
Microbiology of cystic fibrosis persons not chronically infected with : A quasi-experimental study on two different upper airways' sampling methods.非慢性感染的囊性纤维化患者的微生物学:关于两种不同上呼吸道采样方法的准实验研究
Heliyon. 2024 Feb 29;10(5):e26978. doi: 10.1016/j.heliyon.2024.e26978. eCollection 2024 Mar 15.
2
Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.囊性纤维化患者上、下呼吸道中针对铜绿假单胞菌的抗体反应及其与免疫介质的关系。
Pediatr Pulmonol. 2020 Apr;55(4):959-967. doi: 10.1002/ppul.24671. Epub 2020 Feb 5.
3
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.囊性纤维化患者上、下呼吸道分离出的铜绿假单胞菌和金黄色葡萄球菌的基因型一致。
Thorax. 2009 Jun;64(6):535-40. doi: 10.1136/thx.2008.104711. Epub 2009 Mar 11.
4
Importance of bacteriology in upper airways of patients with Cystic Fibrosis.重视囊性纤维化患者上呼吸道的细菌学检查。
J Cyst Fibros. 2013 Sep;12(5):525-9. doi: 10.1016/j.jcf.2013.01.002. Epub 2013 Jan 26.
5
Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis.囊性纤维化咳痰和不咳痰患者的呼吸道细菌培养采样
Front Pediatr. 2018 Dec 18;6:403. doi: 10.3389/fped.2018.00403. eCollection 2018.
6
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2013 Dec 23(12):CD009530. doi: 10.1002/14651858.CD009530.pub2.
7
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2016 Jan 21(1):CD009530. doi: 10.1002/14651858.CD009530.pub3.
8
Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.金黄色葡萄球菌定植于 CF 患者的上呼吸道比铜绿假单胞菌更能显著促进上呼吸道炎症。
Med Microbiol Immunol. 2016 Oct;205(5):485-500. doi: 10.1007/s00430-016-0463-0. Epub 2016 Jul 4.
9
Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.囊性纤维化或原发性纤毛运动障碍患者的鼻窦细菌学:一项系统评价。
Am J Rhinol Allergy. 2017 Sep 1;31(5):293-298. doi: 10.2500/ajra.2017.31.4461.
10
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.

本文引用的文献

1
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.推进囊性纤维化临床试验管道:具有全球试验网络视角的新路线图。
Lancet Respir Med. 2023 Oct;11(10):932-944. doi: 10.1016/S2213-2600(23)00297-7. Epub 2023 Sep 9.
2
Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy.理解并满足囊性纤维化患者在 CFTR 调节剂治疗时代的需求。
Lancet Respir Med. 2023 Oct;11(10):916-931. doi: 10.1016/S2213-2600(23)00324-7. Epub 2023 Sep 9.
3
CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.
CFTR 调节剂治疗:改变囊性纤维化临床治疗格局。
Lancet. 2023 Sep 30;402(10408):1171-1184. doi: 10.1016/S0140-6736(23)01609-4. Epub 2023 Sep 9.
4
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches.囊性纤维化治疗的未来:从疾病机制到新型治疗方法。
Lancet. 2023 Sep 30;402(10408):1185-1198. doi: 10.1016/S0140-6736(23)01608-2. Epub 2023 Sep 9.
5
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.依伐卡托钠/泰比卡托钠/埃他卡托钠在 和最小功能突变杂合子且年龄在 6 至 11 岁的囊性纤维化儿童中的疗效和安全性:一项 3b 期、随机、安慰剂对照研究。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1361-1369. doi: 10.1164/rccm.202202-0392OC.
6
Worldwide rates of diagnosis and effective treatment for cystic fibrosis.全球囊性纤维化的诊断和有效治疗率。
J Cyst Fibros. 2022 May;21(3):456-462. doi: 10.1016/j.jcf.2022.01.009. Epub 2022 Feb 4.
7
Cystic fibrosis.囊性纤维化。
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
8
Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present.托斯卡纳的囊性纤维化:随着时间的推移,新生儿筛查策略的演变至今。
Ital J Pediatr. 2021 Jan 6;47(1):2. doi: 10.1186/s13052-020-00948-8.
9
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.用于囊性纤维化的预防性抗葡萄球菌抗生素。
Cochrane Database Syst Rev. 2020 Sep 30;9(9):CD001912. doi: 10.1002/14651858.CD001912.pub5.
10
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.